High-risk Medical Devices Variable evidence after approval Comment

被引：0
|
作者：
Zens, Yvonne [1 ]
机构：
[1] IQWiG, Cologne, Germany
来源：
PNEUMOLOGIE | 2016年 / 70卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] SYSTEMATIC REVIEW OF STRENGTH OF EVIDENCE SUPPORTING THE APPROVAL AND CLINICAL USE OF HIGH-RISK MEDICAL DEVICES IN CARDIOVASCULAR MEDICINE: AN UPDATE FROM THE CORE-MD CONSORTIUM
    McGovern, L.
    Siontis, G.
    Frenk, A.
    Melvin, T.
    McGauran, G.
    Geertsma, R.
    Schnell-Inderst, P.
    Fraser, Ag
    Windecker, S.
    Byrne, R.
    HEART, 2022, 108 : A21 - A21
  • [22] Market of First Launch for High-Risk Therapeutic Medical Devices
    Kadakia, Kushal T.
    Lalani, Christina
    Kramer, Daniel B.
    Orui, Hibiki
    Yeh, Robert W.
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [23] Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices
    Dhruva, Sanket S.
    Mazure, Carolyn M.
    Ross, Joseph S.
    Redberg, Rita F.
    JAMA INTERNAL MEDICINE, 2017, 177 (09) : 1390 - 1391
  • [24] Hospital Pharmacists give support for centralised authorisation of high-risk medical devices Hospital Pharmacists give support for centralised authorisation of high-risk medical devices
    Price, Richard
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2013, 20 (06): : 373 - 373
  • [25] Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)
    Fraser, A. G.
    Nelissen, R. G. H. H.
    Kjaersgaard-Andersen, P.
    Szymanski, P.
    Melvin, T.
    Piscoi, P.
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (03) : 249 - 258
  • [26] Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)
    Fraser, A. G.
    Nelissen, R. G. H. H.
    Kjaersgaard-Andersen, P.
    Szymanski, P.
    Melvin, T.
    Piscoi, P.
    EFORT OPEN REVIEWS, 2021, 6 (10) : 839 - 849
  • [27] Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose?
    Klein, Philip
    Blommestein, Hedwig
    Al, Maiwenn
    Pongiglione, Benedetta
    Torbica, Aleksandra
    de Groot, Saskia
    HEALTH ECONOMICS, 2022, 31 : 10 - 24
  • [28] DIVERGENT EVIDENCE REQUIREMENTS COMPARING THE AUTHORIZATION AND REIMBURSEMENT PROCESSES OF HIGH-RISK MEDICAL DEVICES - THE EUROPEAN SITUATION
    Krueger, L. J.
    Evers, S. M.
    Hiligsmann, M.
    Wild, C.
    VALUE IN HEALTH, 2014, 17 (03) : A12 - A12
  • [29] Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014
    Rathi, Vinay K.
    Wang, Bo
    Ross, Joseph S.
    Downing, Nicholas S.
    Kesselheim, Aaron S.
    Gray, Stacey T.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 156 (02) : 285 - 288
  • [30] Recalls and Premarket Review Systems for High-Risk Medical Devices in Japan
    Nakayama, Motoko
    Tanaka, Shiro
    Hamada, Shota
    Uchida, Takahiro
    Kawakami, Koji
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (06) : 775 - 780
12345